| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 12/16/2009 | EP2133336A1 Modified metal complexes and use thereof |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2132987A1 Nematicidal agent composition and method of using the same |
| 12/16/2009 | EP2132177A1 Pim kinase inhibitors and methods of their use |
| 12/16/2009 | EP2131843A2 Process for the synthesis of glyt-1 inhibitors |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |
| 12/16/2009 | CN101605761A Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of HGFR gene |
| 12/16/2009 | CN101605760A Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines |
| 12/16/2009 | CN101602781A Metal-string material connected with aromatic dibasic acid and method for preparing same |
| 12/16/2009 | CN101602722A Synthesis method of 3-cyanopyridine |
| 12/16/2009 | CN101602721A Method for synthesizing 2-cyano-3,6-dichloropyridine |
| 12/16/2009 | CN101602720A Synthesis method of 2-cyanopyridine |
| 12/16/2009 | CN101602719A Synthesis method of 4-cyanopyridine |
| 12/16/2009 | CN101602718A Method for preparing high-purity nicotinamide compound |
| 12/16/2009 | CN101602717A Method for synthesizing 2-chloronicotinic acid |
| 12/16/2009 | CN101602716A Synthesis method of 2-chromium picolinate |
| 12/16/2009 | CN101602715A Synthesis method of 2-picolinic acid |
| 12/16/2009 | CN101602714A Novel method for synthesizing 2-chloronicotinic acid |
| 12/16/2009 | CN101602713A Novel method for synthesizing 2-chloronicotinic acid |
| 12/16/2009 | CN101602712A Novel method for synthesizing 2-fluoro-3-chloro-5-trifluoromethylpyridine |
| 12/16/2009 | CN101602711A Microporous coordination polymer material based on 4-(4-pyridyl) acidum benzoicum and preparation method and application thereof |
| 12/16/2009 | CN101602657A Halogenated hydroxyl arone compounds, preparation method and use thereof |
| 12/16/2009 | CN101602653A Halogenated hydroxyl aromatic methane compounds, preparation method and use thereof |
| 12/16/2009 | CN100569767C Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 12/16/2009 | CN100569754C Synthesis and application of serial ion liquid as candidate drug with anticancer activity |
| 12/16/2009 | CN100569752C Process for conversion of cyanopyridines to niacinamide and catalyst therefor, process for preparing the catalyst |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632945 Cyanine dye |
| 12/15/2009 | US7632879 Intercalant/exfoliant, comprising an azinium compound capable of splaying a layered material; layered materials can be dispersed in a polymeric phase through an environmentally acceptable water or solvent-borne medium to form nanocomposites with desirable properties |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/15/2009 | US7632839 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction |
| 12/15/2009 | CA2502264C N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 12/10/2009 | WO2009149188A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 12/10/2009 | WO2009148052A1 Sulfonamide compound and application thereof |
| 12/10/2009 | WO2009148004A1 Novel compound and pharmaceutical application of same |
| 12/10/2009 | WO2009147682A1 Novel modulators of protein kinase signaling |
| 12/10/2009 | WO2009147221A1 Small molecule leptin receptor modulators |
| 12/10/2009 | WO2009147216A1 New pyridine derivatives as leptin receptor modulator mimetics |
| 12/10/2009 | WO2009147211A1 New compounds v |
| 12/10/2009 | WO2009147149A1 Compounds comprising a cyclobutoxy group |
| 12/10/2009 | WO2009146910A1 4, 6-diphenylpyrid-2-0nes against cancer |
| 12/10/2009 | WO2009146555A1 Hiv integrase inhibitors from pyridoxine |
| 12/10/2009 | WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/10/2009 | WO2009123704A3 Process for preparing bis(thiohydrazide amides) |
| 12/10/2009 | WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity |
| 12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
| 12/10/2009 | US20090306112 Antiviral protease inhibitors |
| 12/10/2009 | US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 12/10/2009 | US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 12/10/2009 | US20090306022 7-substituted tetracycline compounds |
| 12/10/2009 | US20090306020 Combination therapy comprising diaryl ureas for treating diseases |
| 12/10/2009 | US20090306016 Fatty acid amide hydrolase inhibitors |
| 12/10/2009 | US20090300857 Dyes containing a thiol group |
| 12/10/2009 | US20090300856 Specific monocationic monochromophoric compounds of hydrazone type comprising a 2-, 4-pyridinium or 2-, 4-quinolinium unit, synthesis thereof, dye compositions containing them, and method for dyeing keratin fibres |
| 12/10/2009 | CA2726939A1 4,6-diphenylpyrid-2-ones against cancer |
| 12/10/2009 | CA2726742A1 Hiv integrase inhibitors from pyridoxine |
| 12/10/2009 | CA2726610A1 Sulfonamide compounds and use thereof |
| 12/10/2009 | CA2726588A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 12/10/2009 | CA2726441A1 New pyridine derivatives as leptin receptor modulator mimetics |
| 12/10/2009 | CA2726270A1 Small molecule leptin receptor modulators |
| 12/10/2009 | CA2723626A1 Compounds comprising a cyclobutoxy group |
| 12/10/2009 | CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/09/2009 | EP2130820A1 Antipruritics |
| 12/09/2009 | EP2129654A1 Novel antagonists of the glucagon receptor |
| 12/09/2009 | EP2129653A2 Novel p2y12 receptor antagonists |
| 12/09/2009 | EP2129652A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 12/09/2009 | EP1991529B1 Substituted arylsulfonamides as antiviral agents |
| 12/09/2009 | EP1701942B1 Non-nucleotide reverse transcriptase inhibitors |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/09/2009 | EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 12/09/2009 | EP1182183B1 Anthracene derivatives and organic electroluminescent devices made by using the same |
| 12/09/2009 | EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 12/09/2009 | EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 12/09/2009 | CN101600683A Therapeutic compounds |
| 12/09/2009 | CN101597258A Technique for synthesizing niacinamide and co-producing niacin by hydrolyzing 3-cyanopyridine |
| 12/09/2009 | CN101597257A Synthesis method of 2-zinc picolinate |
| 12/09/2009 | CN101597256A Preparation method of paraquat derivatives |
| 12/09/2009 | CN101597255A Organic material and application thereof in organic electroluminescence device (OELD) |
| 12/09/2009 | CN100567471C Use of metal complex compounds as oxidation catalysts |
| 12/09/2009 | CN100567269C 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100567264C Dendritic molecule and dendritic macromolecule, method of producing the same, and method of producing thioacetal compound |
| 12/09/2009 | CN100567242C Hsp90 family protein inhibitors |
| 12/08/2009 | US7629472 Preparing a beta-hydroxy-beta-heteroaryl ester by reacting a beta-halozinc ester Reformatsky reagent with an alpha-carbonylheteroaryl compound in the presence of a cinchona alkaloid; the heteroaryl is preferably an optionally substituted 2-pyridyl group or 4-imidazolyl group; stereospecific; drugs |
| 12/08/2009 | US7629471 Transcriptional factor, process for producing the same and use thereof |
| 12/08/2009 | US7629470 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 12/08/2009 | US7629368 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 12/08/2009 | US7629367 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 12/08/2009 | US7629366 Aminoalcohol derivatives |
| 12/08/2009 | US7629364 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629348 Insecticides; for human or veterinary medicine |
| 12/08/2009 | US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
| 12/08/2009 | CA2449451C A novel synthesis for heteroarylamine compounds |